This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB06939/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06939/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06939/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB06939/identifier/chemspider/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB06939/identifier/pdb/

Statements

Subject Item
n2:DB06939
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB06939 n14:DB06939
dcterms:title
N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE
adms:identifier
n8:99443410 n9:277 n10:16122596 n11:17279511 n12:DB06939
n3:IUPAC-Name
n4:271B60C1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B60C7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B60C6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B60C3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B60C4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B60C5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B60BF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B60C0-363D-11E5-9242-09173F13E4C5 n4:271B60BD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B60BE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B60CD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B60CE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B60C8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B60C9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B60CB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B60CA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B60CC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B60D2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B60D4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B60D5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B60D1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B60D0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B60D3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B60C2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B60CF-363D-11E5-9242-09173F13E4C5